Clinical Trials Browser

Phase 1 × sintilimab × 90 days × Clear all

NCT07455617 2026-04-06

Study of ABO2102 in KRAS-Mutated Solid Tumors

Phase 1 Recruiting

Neoplasm Metastasis

NCT05427487 2026-03-25

Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours

Phase 1 Recruiting

GastrointestinalGynecologic

Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms